Grown Rogue International (GRUSF) Total Debt (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Total Debt came in at $9.9 million in Q1 2026, down 1.03% quarter-over-quarter from $10.0 million in Q4 2025.
Grown Rogue International (GRUSF) Total Debt (2009 - 2026) Analysis & Trends
Grown Rogue International's Total Debt history runs 16 years deep, the most recent figure standing at $9.9 million for Q1 2026.
- On a quarterly basis, Total Debt changed N/A year-over-year to $9.9 million in Q1 2026; TTM through Mar 2026 was $9.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $10.0 million, changed N/A from the prior year.
- Total Debt declined to $9.9 million in Q1 2026 per GRUSF's latest filing, from $10.0 million in the prior quarter.
- Across five years, Total Debt topped out at $10424.6 billion in Q3 2025 and bottomed at $498987.0 in Q2 2023.
- The 4-year median for Total Debt is $1.2 million (2024), against an average of $1158.3 billion.
- Biggest YoY gain for Total Debt was 922180181.77% in 2025; the steepest drop was 458.08% in 2025.
- Year by year, Total Debt stood at $840844.1 in 2023, then surged by 34.44% to $1.1 million in 2024, then jumped by 786.32% to $10.0 million in 2025, then decreased by 1.03% to $9.9 million in 2026.
- Per Business Quant, the three latest GRUSF Total Debt figures stand at $9.9 million (Q1 2026), $10.0 million (Q4 2025), and $10424.6 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 9.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.92 Mn |
| Dec 31, 2025 | 10.02 Mn |
| Sep 30, 2025 | 10,424.63 Bn |
| Jun 30, 2025 | 6.59 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Dec 31, 2023 | 840,844.06 |
| Apr 30, 2023 | 498,987.00 |
| Jan 31, 2023 | 534,090.00 |
| Apr 30, 2021 | 1.17 Mn |
| Jan 31, 2021 | 1.05 Mn |
| Oct 31, 2020 | 799,814.00 |
| Jul 31, 2020 | 485,855.00 |
| Apr 30, 2020 | 585,191.00 |
| Oct 31, 2019 | 150,000.00 |
| Jul 31, 2019 | 50,000.00 |
| Apr 30, 2019 | 50,000.00 |
| Jan 31, 2019 | 50,000.00 |
| Oct 31, 2018 | 50,000.00 |
| Aug 31, 2018 | 98,773.24 |